Fei Li

Case report: Dramatic response to alectinib in a lung adenosquamous carcinoma patient harbouring a novel CPE-ALK fusion

Q. Zhang, Yanyan Qin, Y. Tan, 2022, Frontiers in Oncology.

DW-MRI as a Biomarker to Compare Therapeutic Outcomes in Radiotherapy Regimens Incorporating Temozolomide or Gemcitabine in Glioblastoma

T. Mikkelsen, T. Chenevert, B. Ross, 2012, PloS one.